Grading of prostate cancer: a work in progress

por Kweldam, C F, van Leenders, G J, van der Kwast, T
Publicado 2018

Haemodynamic Benefit of Cardiac Resynchronisation Therapy Requires Left Bundle Branch Block: A Case Report

por Bogaard, M. D., Leenders, G. E., Doevendans, P. A., Meine, M.
Publicado 2011

The lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and review

por Blok, F., Roes, E. M., van Leenders, G. J. L. H., van Beekhuizen, H. J.
Publicado 2016

The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation

por Lagerveld, B. W., van Dekken, H., van Leenders, G. J. L. H., van der Zee, J. A.
Publicado 2012

Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients

por Rozemeijer, R., Wing Wong, C., Leenders, G., Timmers, L., Koudstaal, S., Rittersma, S. Z., Kraaijeveld, A., Bots, M., Doevendans, P., Stella, P., Voskuil, M.
Publicado 2019

The CHASIT study: sequential chemo-immunotherapy in patients with locally advanced urothelial cancer – a non-randomized phase II clinical trial

por Rutten, V. C., Salhi, Y., Robbrecht, G. J., de Wit, R., van Leenders, G. J.L.H., Zuiverloon, T. C.M., Boormans, J. L.
Publicado 2023

E17K substitution in AKT1 in prostate cancer

por Boormans, J L, Korsten, H, Ziel-van der Made, A C J, van Leenders, G J L H, Verhagen, P C M S, Trapman, J
Publicado 2010

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer

por Puhr, M, Hoefer, J, Eigentler, A, Dietrich, D, van Leenders, G, Uhl, B, Hoogland, M, Handle, F, Schlick, B, Neuwirt, H, Sailer, V, Kristiansen, G, Klocker, H, Culig, Z
Publicado 2016

The Coronary Sinus Reducer; 5-year Dutch experience

por Silvis, M. J. M., Dekker, M., Zivelonghi, C., Agostoni, P., Stella, P. R., Doevendans, P. A., de Kleijn, D. P. V., van Kuijk, J. P., Leenders, G. E., Timmers, L.
Publicado 2020

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial

por Hinsenveld, F. J., Noordman, B. J., Boormans, J. L., Voortman, J., van Leenders, G. J. L. H., van der Pas, S. L., van Beek, S. C., Oprea-Lager, D. E., Vis, A. N.
Publicado 2021

Cellular origin of microRNA‐371a‐3p in healthy males based on systematic urogenital tract tissue evaluation

por Boellaard, W. P. A., Gillis, A. J. M., van Leenders, G. J. L. H., Stoop, H., van Agthoven, T., Dorssers, L. C. J., Dinkelman‐Smit, M., Boormans, J. L., Looijenga, L. H. J.
Publicado 2019

Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in v...

por Goderie, T. P. M., van Soest, G., Garcia-Garcia, H. M., Gonzalo, N., Koljenović, S., van Leenders, G. J. L. H., Mastik, F., Regar, E., Oosterhuis, J. W., Serruys, P. W., van der Steen, A. F. W.
Publicado 2010

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours

por Rijlaarsdam, M A, van Herk, H A D M, Gillis, A J M, Stoop, H, Jenster, G, Martens, J, van Leenders, G J L H, Dinjens, W, Hoogland, A M, Timmermans, M, Looijenga, L H J
Publicado 2011

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours

por Rijlaarsdam, M A, van Herk, H A D M, Gillis, A J M, Stoop, H, Jenster, G, Martens, J, van Leenders, G J L H, Dinjens, W, Hoogland, A M, Timmermans, M, Looijenga, L H J
Publicado 2012

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progr...

por Böttcher, R, Henderson, D J P, Dulla, K, van Strijp, D, Waanders, L F, Tevz, G, Lehman, M L, Merkle, D, van Leenders, G J L H, Baillie, G S, Jenster, G, Houslay, M D, Hoffmann, R
Publicado 2015

Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial

por Rozemeijer, R., van Bezouwen, W. P., van Hemert, N. D., Damen, J. A., Koudstaal, S., Stein, M., Leenders, G. E., Timmers, L., Kraaijeveld, A. O., Roes, K., Agostoni, P., Doevendans, P. A., Stella, P. R., Voskuil, M.
Publicado 2020

Radiomics approach to distinguish between well differentiated liposarcomas and lipomas on MRI

por Vos, M., Starmans, M. P. A., Timbergen, M. J. M., van der Voort, S. R., Padmos, G. A., Kessels, W., Niessen, W. J., van Leenders, G. J. L. H., Grünhagen, D. J., Sleijfer, S., Verhoef, C., Klein, S., Visser, J. J.
Publicado 2019

Randomised comparison of a balloon-expandable and self-expandable valve with quantitative assessment of aortic regurgitation using magnetic resonance imaging

por Kooistra, N. H. M., Abawi, M., Voskuil, M., Urgel, K., Samim, M., Nijhoff, F., Nathoe, H. M., Doevendans, P. A. F. M., Chamuleau, S. A. J., Leenders, G. E. H., Leiner, T., Abrahams, A. C., van der Worp, H. B., Agostoni, P., Stella, P. R.
Publicado 2020

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer

por Zoni, E, Chen, L, Karkampouna, S, Granchi, Z, Verhoef, E I, La Manna, F, Kelber, J, Pelger, R C M, Henry, M D, Snaar-Jagalska, E, van Leenders, G J L H, Beimers, L, Kloen, P, Gray, P C, van der Pluijm, G, Kruithof-de Julio, M
Publicado 2017

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies

por de Joode, K., van de Geer, W. S., van Leenders, G. J. L. H., Hamberg, P., Westgeest, H. M., Beeker, A., Oosting, S. F., van Rooijen, J. M., Beerepoot, L. V., Labots, M., Mathijssen, R. H. J., Lolkema, M. P., Cuppen, E., Sleijfer, S., van de Werken, H. J. G., van der Veldt, A. A. M.
Publicado 2023